Furthermore, the Keap1-Nrf2-SOD pathway showed that T-MSCs can upregulate the expression of the antioxidant enzymes SOD-1 and SOD-2, and increase nuclear Nrf2 expression, further enhancing the antioxidant ability of PD. This evidence concerns the gene KEAP1 and Parkinson disease.